Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
Clinical trial NCT00700778 · TERMINATED
Trial details
- NCT number
- NCT00700778
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.